{"id":45296,"title":"Genotyping of the rs1695 polymorphism of the GSTP1 gene by PCR-RFLP","title_html":"<p>Genotyping of the rs1695 polymorphism of the <em>GSTP1 <\/em>gene by PCR-RFLP<\/p>","image":{"source":"https:\/\/s3.amazonaws.com\/protocols-files\/files\/c3nbbhj67.jpg","placeholder":"https:\/\/s3.amazonaws.com\/protocols-files\/files\/c3nbbhj67.jpg"},"doi":"dx.doi.org\/10.17504\/protocols.io.bqgqmtvw","doi_status":2,"uri":"genotyping-of-the-rs1695-polymorphism-of-the-gstp1-bqgqmtvw","type_id":1,"template_id":1,"published_on":1613837166,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"bqgqmtvw","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1607352471,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"kamilla_fariasantos ","affiliation":null,"affiliations":[],"username":"m4vle1x1r1t4wle1","note":null,"link":"https:\/\/doi.org\/10.1371\/journal.pone.0247024","image":{"source":"\/img\/avatars\/015.png","placeholder":"\/img\/avatars\/015.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":"PLOS One","journal_name":"PLOS One","journal_link":"https:\/\/doi.org\/10.1371\/journal.pone.0247024","article_citation":"Barros JBdS,  Santos KdF,  Azevedo RM,  Oliveira RPDd,  Leobas ACD,  Bento DdCP,  Santos RdS,  Reis AAdS (2021) No association of <i>GSTP1<\/i> rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population. PLoS ONE  16(2): e0247024. doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0247024\">10.1371\/journal.pone.0247024<\/a> ","has_versions":0,"link":"https:\/\/doi.org\/10.1371\/journal.pone.0247024","total_collections":0,"number_of_steps":5,"authors":[{"name":"J\u00e9ssica Barletto de Sousa Barros","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Kamilla de Faria Santos","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"R\u00f4mulo Morais Azevedo","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Rayana Pereira Dantas de Oliveira","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Ana Carolina Dourado Leobas","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Dhiogo da Cruz Pereira Bento","affiliation":"Rehabilitation and Readaptation Medical Center Dr. Henrique Santillo (CRER), Goi\u00e2nia, Goi\u00e1s, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Rodrigo da Silva Santos","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Angela Adamski da Silva Reis","affiliation":"Laboratory of Molecular Pathology, Department of Biochemistry and Molecular Biology, Institute of Biological Sciences, Federal University of Goi\u00e1s (UFG), Goi\u00e2nia, GO, Brazil.","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/genotyping-of-the-rs1695-polymorphism-of-the-gstp1-bqgqmtvw","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"2B0A6540389B11EB8A457100AEC38DB4","state_version_id":553,"steps":[{"id":1090117,"guid":"911172203A2611EBA0523B31DEE94734","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"72E5327C3A8E4BCA96136F56438F8710","order_id":1,"type_id":6,"title":"Section","source":{"title":"DNA extraction"}},{"id":1054724,"guid":"889116AA3FE9411F850B7337E9F54C1C","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>    DNA samples were isolated from peripheral blood using DNA extraction kit (Invitrogen\u00ae), according to the manufacturer's instructions.<\/span><span style = \"font-style:italic;\"> GSTP1 <\/span><span>rs1695 variant was genotyped through PCR-RFLP method.<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#800673","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1090120,"guid":"1F68A7A03A2711EBA0523B31DEE94734","previous_id":1090201,"previous_guid":"11C3F5903A2811EBA0523B31DEE94734","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"A7C496C641E343F9B64D066F732F0665","order_id":1,"type_id":6,"title":"Section","source":{"title":"GSTP1 gene amplification by PCR"}},{"id":1054724,"guid":"F2476EAC5BD14C56AA3872B9E2053883","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>    A conventional polymerase chain reaction (PCR) was performed to amplify the 176 base pairs (bp) region of the <\/span><span style = \"font-style:italic;\">GSTP1<\/span><span> gene. PCR mixture had a total of 25 \u03bcl per reaction, which contained 2.5 \u03bcL 10X PCR Buffer, 0.5 \u03bcL 0.2 mM  dNTP Mix, 1 \u03bcL  of primer mix, containing forward primer (1.0 uM) and reverse primer (1.0 uM) , 0.5 \u03bcL 50 mM MgCl<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, 0.5 \u03bcL (1.25 U) of Taq DNA polymerase, 18 \u03bcL of Milli-Q Water, and 2 \u03bcL of DNA. <\/span><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:left\"><span>    PCR amplification was carried out with the Bio-rad thermocycler (T100<\/span><span style = \"vertical-align:super;\">TM<\/span><span> Thermal Cycler). Cycling conditions were 94\u00b0C for 5 min for initial denaturation, followed by 35 cycles of denaturation at 94 \u00b0 C for 1 min, annealing at 61 \u00b0 C for 1 min, and extension at 72\u00b0 C for 1:30 min. A final polymerization step of 72\u00b0C for 7 min was performed to complete the elongation processes.<\/span><\/div><\/div><div class = \"text-block\"><span>    A mixture of 6\u03bcl of PCR product and 4 \u03bcl of 6\u00d7 DNA loading buffer run on 12% polyacrylamide gel in  1X TBE buffer<\/span><span style = \"font-style:italic;\">. <\/span><span>A standard DNA ladder (100 bp) was used as a reference. After 240 min under 80V, the polyacrylamide gel was stained with silver nitrate. The presence of a 176 bp fragment confirmed the amplification of the PCR product, allowing subsequent steps to be carried out. Negative controls (PCR mix without DNA) were included in all PCR and electrophoresis assays.<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#50e3c2","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1090121,"guid":"2E3CE3903A2711EBA0523B31DEE94734","previous_id":1090200,"previous_guid":"E6E254203A2711EBA0523B31DEE94734","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"6529937AF7354567A2F35CE7F66F1922","order_id":1,"type_id":6,"title":"Section","source":{"title":"Analysis and interpretation of the results"}},{"id":1054724,"guid":"CFBAE66ED3344D66BE67D4F505CCA9A9","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><div class = \"justify\" style = \"text-align:left\"><span>    The interpretation of the genotyping of <\/span><span style = \"font-style:italic;\">GSTP1<\/span><span> rs1695 polymorphism is based on the activity of the enzyme Alw26I. It recognizes the restriction site of the polymorphic variant (GTCTC(1\/5)^) and promotes a cut in the 176 bp fragment, generating two fragments (85 and 91 bp). Thus, in the wild genotype (AA), which does not have the enzyme restriction site, the fragment remains unchanged (176 bp), while the heterozygous genotype (AG) is determined by the presence of three fragments  (85, 91, and 176 bp). On the other hand,  the mutant genotype (GG) is characterized by two fragments (85 and 91 bp), Figure 1.<\/span><\/div><\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:left\"><\/div><\/div><div style = \"text-align :; float : ;\"><img style = \"\" src = \"https:\/\/s3.amazonaws.com\/protocols-files\/files\/c3ndbhj67.jpg\" \/><\/div><\/div>"}},{"id":1054725,"guid":"C7EEA514392846AAA3B89082AC2D6E89","order_id":2,"type_id":1,"title":"description","source":{"description":"<div style = \"text-align :; float : ;\"><img style = \"\" src = \"https:\/\/s3.amazonaws.com\/protocols-files\/files\/c3ndbhj67.jpg\" \/><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#87cf87","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1090200,"guid":"E6E254203A2711EBA0523B31DEE94734","previous_id":1090120,"previous_guid":"1F68A7A03A2711EBA0523B31DEE94734","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"779912EA9D0F47DD96B4724CC0647D5F","order_id":1,"type_id":6,"title":"Section","source":{"title":"Genotyping of GSTP1 rs1695 polymorphism by PCR-RFLP"}},{"id":1054724,"guid":"FCDF86F813864F699C1C0D26C5ACBB4A","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>    Amplified 176bp products were digested with <\/span><span style = \"font-style:italic;\">Alw26I <\/span><span>(Thermo Scientific<\/span><span style = \"vertical-align:super;\">TM<\/span><span>) restriction enzyme, using the Bio-rad thermocycler (T100<\/span><span style = \"vertical-align:super;\">TM<\/span><span> Thermal Cycler) under the following cycling conditions: 12 h (37\u00baC) and 20 min (65\u00baC). The reactions (final volume 30 \u03bcL) contained: 2 \u03bcL of 10X Buffer Tango, 17 \u03bcL of Milli-Q Water, 1U of the restriction enzyme, and 10 \u03bcL of the amplified product.<\/span><\/div><div class = \"text-block\"><span>    After this step,10 \u03bcL of the digested product and 4 \u03bcl of 6\u00d7 DNA loading buffer run on 12% polyacrylamide gel in 1X TBE buffer<\/span><span style = \"font-style:italic;\">. <\/span><span>A standard DNA ladder (50bp) was used as a reference. After 360 min under 80V, the polyacrylamide gel was stained with silver nitrate. In all electrophoresis assays, positive controls (sample previously known as heterozygous genotype) were included. All gels were registered with the photo-documenter L-Pix Ex (Loccus Biotecnologia\u00ae).<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#ec23e7","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1090201,"guid":"11C3F5903A2811EBA0523B31DEE94734","previous_id":1090117,"previous_guid":"911172203A2611EBA0523B31DEE94734","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"8CF1E8C349AB4E1E851EBB89CFCCEF8E","order_id":1,"type_id":6,"title":"Section","source":{"title":"Primer design"}},{"id":1054724,"guid":"575BEEDDF5CE4631A08F95D4BC38C95E","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>    The set of primers previously described by Harries <\/span><span style = \"font-style:italic;\">et al.<\/span><span> (1997) (forward: 5\u2019-ACC CCA GGG CTC TAT GGG AA-3\u2019 and reverse: 5\u2019-TGA GGG CAC AAG AAG CCC CT-3\u2019) were used to amplify the fragment of interest of the <\/span><span style = \"font-style:italic;\">GSTP1<\/span><span> gene.<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#6144f3","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":"","materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\"><span>Glutathione S-transferases (GSTs) are enzymes that act in the cellular detoxification of harmful compounds. Due to the role of the GSTP1 isoenzyme in the brain, the presence of the single nucleotide polymorphism (SNP) rs1695 in the <\/span><span style = \"font-style:italic;\">GSTP1<\/span><span> gene may play an important role in the development of neurodegenerative diseases through oxidative stress, one of the main pathogenic mechanisms associated with the degeneration and death of motor neurons.Thus, this protocol provides a standardized methodology for genotyping the rs1695 polymorphism in the <\/span><span style = \"font-style:italic;\">GSTP1<\/span><span> gene through polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (PCR- RFLP). This polymorphism consists of the exchange of adenine for guanine at position 313 (codon 105), which causes the substitution of amino acid isoleucine (Ile) for valine (Val), resulting in a decreased Pi enzyme activity. Polymorphism genotyping techniques have been of great interest in determining the genetic association of several polymorphisms with different diseases, and therefore this protocol may facilitate future genetic studies.<\/span><\/div><\/div>","changed_on":1613837166}